2014
DOI: 10.1089/ten.tea.2013.0207
|View full text |Cite
|
Sign up to set email alerts
|

Design and Characterization of an Injectable Tendon Hydrogel: A Novel Scaffold for Guided Tissue Regeneration in the Musculoskeletal System

Abstract: A biocompatible hydrogel consisting of extracellular matrix (ECM) from human tendons is described as a potential scaffold for guided tissue regeneration and tissue engineering purposes. Lyophilized decellularized tendons were milled and enzymatically digested to form an ECM solution. The ECM solution properties are assessed by proteome analysis with mass spectrometry, and the material's rheological properties are determined as a function of frequency, temperature, and time. In vivo application of the gel in a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
82
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 92 publications
(90 citation statements)
references
References 68 publications
8
82
0
Order By: Relevance
“…Taken together, the data demonstrates that although our pcECM-based gel formulations originate from a porcine source and are combined with chitosan and genipin, the gels are non-immunogenic and are thus good candidates for safe implantation as cardiac scaffolds. These results support our previous work that demonstrated the biocompatibility of a porcine cardiac ECM scaffold [6] as well as the findings of previous studies testing the biocompatibility of decellularized ECM gel, [15,54] genipin [55] and chitosan-based gels. [55][56][57] The biological efficacy of our ECM based hybrid gel formulation was studied in acute and chronic MI rat models.…”
Section: Discussionsupporting
confidence: 92%
“…Taken together, the data demonstrates that although our pcECM-based gel formulations originate from a porcine source and are combined with chitosan and genipin, the gels are non-immunogenic and are thus good candidates for safe implantation as cardiac scaffolds. These results support our previous work that demonstrated the biocompatibility of a porcine cardiac ECM scaffold [6] as well as the findings of previous studies testing the biocompatibility of decellularized ECM gel, [15,54] genipin [55] and chitosan-based gels. [55][56][57] The biological efficacy of our ECM based hybrid gel formulation was studied in acute and chronic MI rat models.…”
Section: Discussionsupporting
confidence: 92%
“…Injectable in situ gelling matrices are the most viable therapeutic option to prevent damage to the anulus fibrosus and future disc degeneration. Substantial work has been performed in other tissue types to create injectable in situ gelling decellularized matrices [37,51,54], but no work exists in the IVD. To date, the only injectable decellularized nucleus pulposus was developed by IllienJünger et al [47].…”
Section: Discussionmentioning
confidence: 99%
“…Kwon et al used pepsin in acetic acid to solubilize cartilage [52]. Others have used modifications of these protocols to solubilize a variety of tissues, including brain [41], liver [53], and tendon [54]. However, these protocols have not yet been adapted to create injectable in situ gelling hydrogels from decellularized nucleus pulposus or IVD tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, these injectable materials can be engineered to display tunable biodegradation under different environmental conditions depending on the chemistry used to form the cross-links. 9,11,12 However, injectable hydrogels are often limited by a relatively low elastic modulus, [13][14][15][16] limiting their utility in applications demanding at least a degree of mechanical strength (e.g. engineering of stiffer tissues such as cartilage, 17 implantation in high-shear environments, 18 or spinal applications 19 ).…”
Section: Introductionmentioning
confidence: 99%